{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:27:25Z","timestamp":1792013245032,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.radonc.2025.110865","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T04:32:26Z","timestamp":1742790746000},"page":"110865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Re-irradiation for children with diffuse intrinsic pontine glioma and diffuse midline glioma"],"prefix":"10.1016","volume":"207","author":[{"given":"Nisha","family":"Shariff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro S.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Tabori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dirks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Keilty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara-Ann","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek S.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110865_b0005","doi-asserted-by":"crossref","unstructured":"Jones C, Perryman L, Hargrave D. Paediatric and adult malignant glioma: close relatives or distant cousins? Nat Rev Clin Oncol 9 400\u2013413 Preprint at https:\/\/doi.org\/10.1038\/nrclinonc.2012.87 (2012).","DOI":"10.1038\/nrclinonc.2012.87"},{"key":"10.1016\/j.radonc.2025.110865_b0010","doi-asserted-by":"crossref","unstructured":"Louis DN et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica 2016;131:803\u2013820 Preprint at https:\/\/doi.org\/10.1007\/s00401-016-1545-1 (2016).","DOI":"10.1007\/s00401-016-1545-1"},{"key":"10.1016\/j.radonc.2025.110865_b0015","doi-asserted-by":"crossref","unstructured":"Smith HL, Wadhwani N, Horbinski C. Major Features of the 2021 WHO Classification of CNS Tumors. Neurotherapeutics 2022;19:1691\u20131704. Preprint at https:\/\/doi.org\/10.1007\/s13311-022-01249-0.","DOI":"10.1007\/s13311-022-01249-0"},{"key":"10.1016\/j.radonc.2025.110865_b0020","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.radonc.2025.110865_b0025","doi-asserted-by":"crossref","unstructured":"Lin C, Smith C, Rutka J. Current immunotherapeutic approaches to diffuse intrinsic pontine glioma. Front Genet, vol. 15, Preprint at https:\/\/doi.org\/10.3389\/fgene.2024.1349612 (2024).","DOI":"10.3389\/fgene.2024.1349612"},{"key":"10.1016\/j.radonc.2025.110865_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.593192","article-title":"Canadian pediatric neuro-oncology standards of practice","volume":"10","author":"Bennett","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110865_b0035","doi-asserted-by":"crossref","unstructured":"Vitanza, NA, Monje M. Diffuse intrinsic pontine glioma: from diagnosis to next-generation clinical trials. Curr Treat Opt Neurol, vol. 21, Preprint at https:\/\/doi.org\/10.1007\/s11940-019-0577-y (2019).","DOI":"10.1007\/s11940-019-0577-y"},{"key":"10.1016\/j.radonc.2025.110865_b0040","first-page":"18","article-title":"Janssens 1,6, chiara valentini 5,7,8, darren hargrave 9","volume":"10","author":"Baugh","year":"2024","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.radonc.2025.110865_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26988","article-title":"Reirradiation in patients with diffuse intrinsic pontine gliomas: the Canadian experience","volume":"65","author":"Lassaletta","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radonc.2025.110865_b0050","article-title":"Re-irradiation for progressive diffuse intrinsic pontine glioma (DIPG): the Spanish experience","volume":"4","author":"Panizo-Morgado","year":"2024","journal-title":"EJC Paediatr Oncol"},{"key":"10.1016\/j.radonc.2025.110865_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.926196","article-title":"Neurological Symptom improvement after re-irradiation in patients with diffuse intrinsic pontine glioma: a retrospective analysis of the SIOP-E-HGG\/DIPG project","volume":"12","author":"Chavaz","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110865_b0060","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/j.ijrobp.2020.07.1419","article-title":"Single institution experience with re-irradiation of diffuse intrinsic pontine gliomas","volume":"108","author":"Zamora","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110865_b0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2018.12.043","article-title":"A phase 1\/2 trial of reirradiation for diffuse intrinsic pontine glioma","volume":"104","author":"Amsbaugh","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110865_b0070","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/jjco\/hyab006","article-title":"Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma","volume":"51","author":"Krishnatry","year":"2021","journal-title":"Jpn J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2025.110865_b0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11060-017-2702-7","article-title":"Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?","volume":"137","author":"Lobon-Iglesias","year":"2018","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.radonc.2025.110865_b0080","article-title":"Craniospinal irradiation as a salvage treatment for metastatic relapsed DIPG","volume":"68","author":"Perez-Somarriba","year":"2021","journal-title":"Pediatr. Blood Can."},{"key":"10.1016\/j.radonc.2025.110865_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1105395","article-title":"A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease","volume":"13","author":"Knox","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110865_b0090","doi-asserted-by":"crossref","unstructured":"M. Massimino, et al., DIPG-04. THE BENEFIT OF CRANIOSPINAL IRRADIATION (CSI) RESCUE IN PHASE 2 RANDOMIZED STUDY OF RADIOTHERAPY (RT), CONCOMITANT NIMOTUZUMAB AND VINORELBINE AND RE-IRRADIATION AT RELAPSE, VERSUS MULTIPLE ELECTIVE RADIOTHERAPY COURSES WITH CONCOMITANT VINORELBINE AND NIMOTUZUMAB FOR NEWLY DIAGNOSED CHILDHOOD AND ADOLESCENCE DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG), Neuro Oncol. 26 (2024) 0\u20130.","DOI":"10.1093\/neuonc\/noae064.058"},{"key":"10.1016\/j.radonc.2025.110865_b0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nou104","article-title":"Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria","volume":"17","author":"Jansen","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.110865_b0100","first-page":"68","article-title":"Reirradiation practices for children with diffuse intrinsic pontine glioma","volume":"8","author":"Cacciotti","year":"2021","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.radonc.2025.110865_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30929","article-title":"Hypofractionated re-irradiation for diffuse intrinsic pontine glioma","volume":"71","author":"Mankuzhy","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radonc.2025.110865_b0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/COC.0b013e318201a2b7","article-title":"Palliative reirradiation for progressive diffuse intrinsic pontine glioma","volume":"35","author":"Fontanilla","year":"2012","journal-title":"Am J Clin Oncol: Can Clin Trials"},{"key":"10.1016\/j.radonc.2025.110865_b0115","first-page":"305","article-title":"Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood","volume":"118","author":"Massimino","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2025.110865_b0120","doi-asserted-by":"crossref","unstructured":"Vanan MI, Eisenstat DD. DIPG in children - What can we learn from the past? Front Oncol, vol. 5, Preprint at https:\/\/doi.org\/10.3389\/fonc.2015.00237, 2015.","DOI":"10.3389\/fonc.2015.00237"},{"key":"10.1016\/j.radonc.2025.110865_b0125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.prro.2016.11.005","article-title":"Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature","volume":"7","author":"Freese","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110865_b0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2016.12.007","article-title":"Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG\/DIPG working group","volume":"73","author":"Janssens","year":"2017","journal-title":"Eur. J. Can."},{"key":"10.1016\/j.radonc.2025.110865_b0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11060-018-2991-5","article-title":"Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience","volume":"140","author":"Kline","year":"2018","journal-title":"J. Neurooncol."}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025001604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025001604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:18:41Z","timestamp":1748002721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025001604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":27,"alternative-id":["S0167814025001604"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110865","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-irradiation for children with diffuse intrinsic pontine glioma and diffuse midline glioma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110865"}}